IPAD-DB ID | S01259 |
Name | Trimethyl(tetradecyl)ammonium bromide |
Category | Synthetic compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 7 H 3 8 B r N |
Molecular Weight | 336.4 g/mol |
IUPAC Name | trimethyl(tetradecyl)azanium;bromide |
InChI | InChI=1S/C17H38N.BrH/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18(2, 3)4;/h5-17H2, 1-4H3;1H/q+1;/p-1 |
InChIKey | CXRFDZFCGOPDTD-UHFFFAOYSA-M |
Canonical SMILES | CCCCCCCCCCCCCC[N+](C)(C)C.[Br-] |
PubChem CID | 14250 |
DrugBank Accession Number | - |
CAS Registry Number | 1119-97-7 |
Molecular Weight(Computed by SwissADME) | 336.39 |
Hac(Computed by SwissADME) | 19 |
Volume(Computed by ADMETlab 2.0) | 314.903 |
Density(Computed by ADMETlab 2.0) | 0.814 |
nRing(Computed by ADMETlab 2.0) | 0 |
MaxRing(Computed by ADMETlab 2.0) | 0 |
nHet(Computed by ADMETlab 2.0) | 1 |
fChar(Computed by ADMETlab 2.0) | 1 |
nRig(Computed by ADMETlab 2.0) | 0 |
Flexibility(Computed by ADMETlab 2.0) | inf |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | 0.007 |
LogD(Computed by ADMETlab 2.0) | 2.136 |
logP(Computed by ADMETlab 2.0) | 4.599 |
TPSA(Computed by SwissADME) | 0 |
Hbond Acceptor(Computed by SwissADME) | 0 |
Hbond Donor(Computed by SwissADME) | 0 |
Rotatable Bonds(Computed by SwissADME) | 13 |
GI Absorption(Computed by SwissADME) | Low |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | Yes |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.85 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 1 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 1 |
Bioavailability Score(Computed by SwissADME) | 0.55 |